Parameters | Plerixafor Group (PY) (N = 28) | Good Mobilizers (PN) (N = 21) |
No. of Collection (Mean) | 2.64 ± 0.48 | 2.47 ± 0.5 |
Median Age (range) | 49.5 (19 - 68) | 53 (18 - 67) |
Gender (%) |
|
|
Male | 13 (46.4%) | 11 (52.4%) |
Female | 15 (53.6%) | 10 (47.6%) |
Induction Chemotherapy (%) |
|
|
Single Line | 16 (57.1%) | 15 (71.4%) |
Multiple Line | 12 (42.9%) | 6 (28.6%) |
Apheresis (Median) |
|
|
D1 | 1.755 (0.258 - 8.52) | 2.63 (1.06 - 6.29) |
D2 | 3.845 (0.317 - 13.89) | 3.18 (0.88 - 6.348) |
D3 | 2.28 (0.24 - 12.29) | 1.61 (0.89 - 3.11) |
Total | 7.56 (3.55 - 18.19) | 7.5 (3.17 - 10.73) |
Neutrophil engraftment (Median) | 11.5 (9 - 22) | 11 (9 - 36) |
Platelet engraftment (Median) | 14 (9 - 98) | 13 (11 - 98) |